4.3.1.4: formimidoyltetrahydrofolate cyclodeaminase
This is an abbreviated version!
For detailed information about formimidoyltetrahydrofolate cyclodeaminase, go to the full flat file.
Word Map on EC 4.3.1.4
-
4.3.1.4
-
autoantibody
-
anti-lc1
-
autoantigens
-
anti-liver
-
liver-specific
-
cyp2d6
-
formiminotransferase-cyclodeaminase
-
anti-lkm-1
-
anti-liver-kidney
-
polyglutamate
-
liver-related
-
microtubule-binding
-
antinuclear
-
medicine
-
asialoglycoprotein
-
analysis
-
diagnostics
- 4.3.1.4
- autoantibody
-
anti-lc1
- autoantigens
-
anti-liver
-
liver-specific
- cyp2d6
- formiminotransferase-cyclodeaminase
-
anti-lkm-1
-
anti-liver-kidney
- polyglutamate
-
liver-related
-
microtubule-binding
-
antinuclear
- medicine
- asialoglycoprotein
- analysis
- diagnostics
Reaction
Synonyms
58K Golgi protein, deaminase, formiminotetrahydrofolate cyclo-, formimidoyltetrahydrofolate cyclodeaminase, formimino-THF cyclodeaminase, Formiminotetrahydrofolate cyclodeaminase, formiminotransferase cyclodeaminase, FTCD
ECTree
Advanced search results
Application
Application on EC 4.3.1.4 - formimidoyltetrahydrofolate cyclodeaminase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
analysis
-
formiminotransferase cyclodeaminase enzyme complex represents a marker with which to explore ER-Golgi dynamics
diagnostics
putative biomarker, FTCD is useful to distinguish early hepatocellular carcinoma from benign tumors such as regenerative nodule or focal nodular hyperplasia
medicine
-
assay to determine N-formimino-L-glutamate in urine, blood and other fluids for folic acid deficiency
medicine
-
23 out of 38 patients with type 2 autoimmune hepatitis are positive for antibodies against enzyme, epitopes are mainly in formiminotransferase region
medicine
autoantibodies of type 2 autoimmune hepatitis patients are directed against the mature, high-molecular form of enzyme